Processing your payment...
Please do not close your browser.

Aerosol Delivery Device Market - Global Growth, Trends and Forecast (2022 - 2029) By Types, By Application, By Regions and By Key Players:3M Company (NYSE: MMM), Johnson and Johnson (NYSE: JNJ),Koninklijke Philips N.V(AMS: PHIA)

24 Jun, 2022 | 119 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the next five years the Aerosol Delivery Device market will register a 6.12% CAGR in terms of revenue, the global market size will reach USD 51.40 Billion by 2029.

Aerosol Delivery Device Market Overview

Aerosol Delivery Devices are portable devices used to deliver medications for chronic obstructive pulmonary disease (COPD) and asthma into the airways. Exacerbations of these persistent diseases are avoided and treated with them. They have the benefit of ensuring that medications are administered precisely where they are needed while avoiding the systemic side effects of medications.

Asthma, COPD, and cystic fibrosis diagnoses are on the rise, and this is expected to create growth prospects for the aerosol delivery devices market. The market for aerosol delivery devices is also significantly influenced by the declining air quality in industrialized regions as a result of rising air pollution. The market for aerosol delivery devices will expand as more major pharmaceutical companies implement digital technology to offer better respiratory problem management solutions and as more products receive product approvals.

Additionally, factors that are projected to propel the market for aerosol delivery devices include an increasing elderly population, an increase in disposable income, fast urbanization, bettering healthcare facilities, and integration of IoT and digitalization in the region's healthcare system.

What is our Aerosol Delivery Device Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029 CAGR

 

CAGR of 6.12% during the review period (2022 to 2029).

 

By Type

  •  Dry Powder Inhaler
  •  Metered Dose Inhaler
  •  Nebulizer

 

By Application

 

  •     Hospital
  •     Clinic
  •     Drugstore
  •     Emergency Center

 

 By Companies

 

 

 

 

3M Company, Merxin Ltd, Aerogen, Inc., Johnson and Johnson, Koninklijke Philips N.V., Glaxosmithkline Plc, Recipharm AB, Merck and Co. Inc., Teva Pharmaceutical Industries Limited, Metall Zug Group, Gerresheimer AG

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Base Year

 

 

2022

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

119

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Who are the Major Players in Aerosol Delivery Device Market?

The Aerosol Delivery Device Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market 3M Company (NYSE: MMM), Merxin Ltd, Aerogen, Inc., Johnson and Johnson (NYSE: JNJ), Koninklijke Philips N.V(AMS: PHIA)., Glaxosmithkline Plc (LON: GSK), Recipharm AB, Merck and Co. Inc., Teva Pharmaceutical Industries Limited, Metall Zug Group, Gerresheimer AG, Novartis and others

Industry News:

In September 2020, GlaxoSmithKline plc and Innoviva, Inc. received FDA approval for Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US.

In July 2020, Novartis received the European Commission (EC) approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside treatment for uncontrolled asthma in the EU.

What are the major Applications, Types and Regions for Aerosol Delivery Device Market?

By Type, it is segmented into

  • Dry Powder Inhaler
  •  Metered Dose Inhaler
  •  Nebulizer

By Applications it is segmented into

  •     Hospital
  •     Clinic
  •     Drugstore
  •     Emergency Center

Aerosol Delivery Device Market Regional Analysis

Countries like China, India, and Japan, among others, provide attractive potential for market expansion. The rising desire for better healthcare, as well as a growth in disposable income, particularly in the Asia-Pacific region, might help the market grow.Because of the rise in healthcare spending, Asia-Pacific has the potential to grow at a rapid pace. Furthermore, rising levels of air pollution and the frequency of chronic diseases would have a favorable impact on the area market.

The market for Aerosol Delivery Device in Asia is predicted to increase rapidly over the next few years, followed by Europe. In Asia, China and India are likely to be the fastest expanding markets.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America

The Aerosol Delivery Device Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Aerosol Delivery Device Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
  4. Key Insights
    1. Pricing Analysis, By Key Regions, 2022
    2. Price Comparison (USD Per Ton) By Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer) 2021/2022
    3. Price Comparison (USD, Per Ton): By Application (Hospital, Clinic, Drugstore, Emergency Center) 2021/2022
    4. Impact of COVID-19 on the Aerosol Delivery Device Market
    5. Production Share of Aerosol Delivery Device, By Region, 2022
    6. Key Industry Developments
  5. Global Aerosol Delivery Device Market Analysis, Insights and Forecast, 2022-2029
    1. Market Analysis, Insights and Forecast – By Application
      1.  Hospital
      2.   Clinic
      3.   Drugstore
      4.   Emergency Center
    2. Market Analysis, Insights and Forecast – By Type
      1. Dry Powder Inhaler
      2.  Metered Dose Inhaler
      3.  Nebulizer
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. 3M Company (NYSE: MMM)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Johnson and Johnson (NYSE: JNJ)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Koninklijke Philips N.V(AMS: PHIA)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Glaxosmithkline Plc (LON: GSK)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla